Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
McKesson
US Army
Medtronic
Merck

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 7,662,552

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,662,552
Title:Method of diagnosing and treating lesion of crystalline lens using human CRYGS gene and coding product thereof
Abstract: The method of diagnosing lesions of crystalline lens such as cataract is disclosed. It comprises detecting variation of crygs gene, transcript and/or protein of individuals compared with normalty. The individual suffers from cataract more possible than normalty when occurring the variation. The present invention also discloses the method and pharmaceutical composition of treating lesions of crystalline lens such as cataract.
Inventor(s): Kong; Xiangyin (Shanghai, CN), Bu; Lei (Shanghai, CN), Zhao; Guoping (Shanghai, CN), Yan; Shunsheng (Shanghai, CN), Jin; Meilei (Shanghai, CN), Sulitang; Yerjiang (Shanghai, CN), Jin; Yiping (Shanghai, CN), Hu; Liandian (Shanghai, CN)
Assignee: Shanghai Institutes of Biological Science, Chinese Academy of Sciences (Shanghai, CN)
Application Number:10/362,817
Patent Claims:see list of patent claims

Details for Patent 7,662,552

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Shanghai Institutes of Biological Science, Chinese Academy of Sciences (Shanghai, CN) 2020-08-25 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Shanghai Institutes of Biological Science, Chinese Academy of Sciences (Shanghai, CN) 2020-08-25 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Shanghai Institutes of Biological Science, Chinese Academy of Sciences (Shanghai, CN) 2020-08-25 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Express Scripts
Mallinckrodt
Fuji
Chinese Patent Office
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.